Psychoneuroendocrinology
Volume 32, Issue 5 , Pages 470-479 , June 2007

Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones

  • Melanie S. Flint

      Affiliations

    • Department of Psychology, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    • ,
  • Andrew Baum

      Affiliations

    • Department of Psychology, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    • Department of Psychiatry, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    • ,
  • William H. Chambers

      Affiliations

    • Department of Immunology, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    • ,
  • Frank J. Jenkins

      Affiliations

    • Department of Pathology, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    • Corresponding Author InformationCorresponding author. Tel.: +14126233233; fax: +14126231119.

Received 22 December 2006 ,Revised 22 February 2007 ,Accepted 27 February 2007.

References 

  1. Armelin MC, Armelin HA. Steroid hormones mediate reversible phenotypic transition between transformed and untransformed states in mouse fibroblasts. Proc. Nat. Acad. Sci. USA. 1978;75:2805–2809
  2. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3:421–429
  3. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003;17(Suppl. 1):S27–S36
  4. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer. 1999;80:880–888
  5. Bianchini R, Nocentini G, Krausz LT, Fettucciari K, Coaccioli S, Ronchetti S, et al. Modulation of pro- and antiapoptotic molecules in double-positive (CD4+CD8+) thymocytes following dexamethasone treatment. J. Pharmacol. Exp. Ther. 2006;319:887–897
  6. Collins AR. The comet assay for DNA damage and repair. Mol. Biotechnol. 2004;26:249–261
  7. Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Nat. Acad. Sci. USA. 1999;96:1059–1064
  8. Djelic N, Anderson D. The effect of the antioxidant catalase on oestrogens, triiodothyronine, and noradrenaline in the Comet assay. Teratogen. Carcin. Mut. Suppl. 2003;2:69–81
  9. Flint MS, Carroll JE, Jenkins FJ, Chambers WH, Han ML, Baum A. Genomic profiling of restraint stress-induced alterations in mouse T lymphocytes. J. Neuroimmunol. 2005;167:34–44
  10. Fox BH. Premorbid psychological factors as related to cancer incidence. J. Behav. Med. 1978;1:45–133
  11. Fox BH. Remote life-style causes of cancer. Cancer Detect. Prev. 1984;7:21–29
  12. Fox BH, Goldsmith JR. Behavioral issues in prevention of cancer. Prev. Med. 1976;5:106–121
  13. Frankenberg-Schwager M. Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionizing radiation. Radiother. Oncol. 1989;14:307–320
  14. Fung H, Bennett RA, Demple B. Key role of a downstream specificity protein 1 site in cell cycle-regulated transcription of the AP endonuclease gene APE1/APEX in NIH3T3 cells. J. Biol. Chem. 2001;276:42011–42017
  15. Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiat. Res. 1999;85:51–61
  16. Glaser R, Thorn BE, Tarr KL, Kiecolt-Glaser JK, D’Ambrosio SM. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol. 1985;4:403–412
  17. Hasegawa H, Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn. J. Cancer Res. 2002;93:729–735
  18. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and cancer: fact or fiction?. Eur. J. Cancer. 1999;35:1603–1607
  19. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and immunotoxicology: implications for carcinogenesis. Psychosom. Med. 1999;61:271–272
  20. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J. Behav. Med. 1985;8:311–320
  21. Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann. Oncol. 2002;13(Suppl. 4):165–169
  22. Levenson JL, Bemis C. The role of psychological factors in cancer onset and progression. Psychosomatics. 1991;32:124–132
  23. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 1996;74:297–312
  24. Lukas J, Lukas C, Bartek J. Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA Repair (Amsterdam). 2004;3:997–1007
  25. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003;9:4514–4521
  26. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001;61:2866–2869
  27. Miura T, Muraoka S, Fujimoto Y, Zhao K. DNA damage induced by catechol derivatives. Chem. Biol. Interact. 2000;126:125–136
  28. Nakane T, Szentendrei T, Stern L, Virmani M, Seely J, Kunos G. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. J. Immunol. 1990;145:260–266
  29. Niida H, Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis. 2006;21:3–9
  30. O’Brien SN, Larcom LL, Baxley EG. Correlates of plasma cortisol and DNA repair in human peripheral lymphocytes: suppression of repair in women taking estrogen. Horm. Res. 1993;39:241–246
  31. Okamoto T, Adachi K, Muraishi A, Seki Y, Hidaka T, Toshima H. Induction of DNA breaks in cardiac myoblast cells by norepinephrine. Biochem. Mol. Biol. Int. 1996;38:821–827
  32. Parsons PG, Morrison LE. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells. Cancer Res. 1982;42:3783–3788
  33. Rupprecht M, Salzer B, Raum B, Hornstein OP, Koch HU, Riederer P, et al. Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls. Exp. Clin. Endocrinol. Diabetes. 1997;105:39–45
  34. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999;22:410–416
  35. Sheppard JR. Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells. Proc. Nat. Acad. Sci. USA. 1977;74:1091–1094
  36. Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 2000;60:153–166
  37. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 2006;12:369–375
  38. Tao W. The mitotic checkpoint in cancer therapy. Cell Cycle. 2005;4:1495–1499
  39. Thrash CR, Ho TS, Cunningham DD. Structural features of steroids which initiate proliferation of density-inhibited 3T3 mouse fibroblasts. J. Biol. Chem. 1974;249:6099–6103
  40. Torbergsen AC, Collins AR. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur. J. Nutr. 2000;39:80–85
  41. van Vugt MA, Medema RH. Checkpoint adaptation and recovery: back with Polo after the break. Cell Cycle. 2004;3:1383–1386
  42. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, et al. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene. 1999;18:127–137
  43. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408:433–439

☆ Supported in part by a grant from the DOD (7-01-1-0373) and from the University of Pittsburgh Cancer Institute.

PII: S0306-4530(07)00054-6

doi: 10.1016/j.psyneuen.2007.02.013

Psychoneuroendocrinology
Volume 32, Issue 5 , Pages 470-479 , June 2007

Article Tools

* Image Usage & Resolution